Trial intelligence / Profile preview

VIXIE: Hyperoxia and Antioxidants in Major Non-cardiac Surgery

NCT03494387Phase 4Completed

Sponsor
Bispebjerg and Frederiksberg Hospital
Start
Apr 2018
Primary completion
Mar 2020
Modality
Inhalation Devices, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of oxygen, ascorbic acid, acetylcysteine in myocardial injury after non-cardiac surgery (MINS), sponsored by Bispebjerg and Frederiksberg Hospital. Started Apr 2018; status: completed.

02

Drugs

oxygenascorbic acidacetylcysteine
03

Conditions

myocardial injury after non-cardiac surgery (MINS)

Beyond the preview

Go deeper on NCT03494387.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03494387.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call